JPH05317406A - Artificial skin - Google Patents

Artificial skin

Info

Publication number
JPH05317406A
JPH05317406A JP4127532A JP12753292A JPH05317406A JP H05317406 A JPH05317406 A JP H05317406A JP 4127532 A JP4127532 A JP 4127532A JP 12753292 A JP12753292 A JP 12753292A JP H05317406 A JPH05317406 A JP H05317406A
Authority
JP
Japan
Prior art keywords
skin
cells
porous membrane
cell
artificial skin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP4127532A
Other languages
Japanese (ja)
Inventor
Ko Oyamada
香 小山田
Mikio Koide
幹夫 小出
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Terumo Corp
Original Assignee
Terumo Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Terumo Corp filed Critical Terumo Corp
Priority to JP4127532A priority Critical patent/JPH05317406A/en
Publication of JPH05317406A publication Critical patent/JPH05317406A/en
Pending legal-status Critical Current

Links

Abstract

PURPOSE:To produce an artificial skin base material allowed to implant onto a part of a lost skin by making a non-proliferative fibroblast derived from an animal on a porous membrane base material while a signal layer of a skin base cell yet to be differentiated is arranged. CONSTITUTION:A 3T3 cell which is made non-prolefirative by irradiation with gammarays is seeded onto a porous membrane base material to be cultivated and then, a skin cell is seeded to be incubated at a specified temperature. As a result, the skin cell yet to be differentiated is arranged to be a signal layer to obtain an artificial skin that allows the implantation of a cell portion onto a wound face of a part of a lost skin without peeling cells off the porous membrane. An example of the porous membrane is that made of polyolefin or the like produced by polymerizing one polymer or more selected from alkoxy alkyl acrylates. A sample of the fibroblast existing on the porous membrane is mouse lung fibroblast, (3T3)., human skin fibroblast or rat skin fibroblast.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は、火傷の皮膚創傷等を治
癒するために用いられる新規な人工皮膚及びその製造方
法に関する。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a novel artificial skin used to heal skin wounds such as burns and a method for producing the same.

【0002】[0002]

【従来の技術】動物細胞の培養技術は、インターフェロ
ン、リンフォカイン、各種の成長ホルモンや細胞増殖因
子などの生理活性物質、生体由来材料及び治療ワクチン
などの生産手段としてあるいは細胞組込型人工臓器の基
本技術として欠かせぬものであり、近年これらの物質を
高効率かつ大量に生産する高密度培養法が注目されてい
る。
2. Description of the Related Art Animal cell culture technology is used as a means of producing interferon, lymphokines, physiologically active substances such as various growth hormones and cell growth factors, biologically derived materials and therapeutic vaccines, or as a basis for cell-incorporated artificial organs. It is an indispensable technique, and in recent years, a high-density culture method for producing these substances with high efficiency and in a large amount has attracted attention.

【0003】動物細胞において、特に生存・増殖・目的
物質の生産のために人工もしくは天然の基材に接着する
ことが「接着依存細胞」の高密度培養では、細胞を培養
する基材表面が細胞の接着性や増殖性の優れた表面であ
ることが必要となってくる。また、細胞の生存や目的物
質の生産能を維持するために、細胞にとって良好な環境
を維持することが重要となり、このため栄養素や酵素の
供給及び老廃物の除去を連続的に行うことが必要となっ
てくる。
In animal cells, particularly in high-density culture of "adhesion-dependent cells", which adhere to an artificial or natural substrate for survival, proliferation, or production of a target substance, the surface of the substrate on which the cells are cultured is the cell. It is necessary that the surface has excellent adhesiveness and proliferation. Also, in order to maintain the survival of cells and the ability to produce target substances, it is important to maintain a favorable environment for cells. Therefore, it is necessary to continuously supply nutrients and enzymes and remove waste products. Will be.

【0004】前者の基材表面への細胞接着性に関して
は、組織培養用プラスチックシャーレとして通常使用し
ているポリスチレン系材料や適度の電荷密度を有する表
面が優れていることが知られている。特開平2−169
72号にスチレン−ジビニルベンゼンの架橋重合体を表
面に保持させた多孔質膜が開示されており、また適度な
電荷密度を有する表面については、ジャーナル オブ
セオロジカル バイオロジー(Journal of Theological
Biology)、第49巻、ページ 417〜424(19
75):アドヘション アンド スプレッディング オ
ブ セルズ オンチャージド サーフェセス(Adhesion
and Spreading of Cells on Charged Sarfaces)に記
載されている。また各種の高分子材料表面に低温プラズ
マ処理、スパッタリング処理、紫外線処理、電子線処
理、単分子累積膜の被覆処理などの表面処理を施した材
料(特公昭58−32589、特開昭63−19896
7、特開昭63−198977、特開平1−15133
など)や、コラーゲン,フィブロネクチン、ヒドロネク
チン、ラミニン等の細胞接着因子や細胞増殖因子などで
処理した材料(例えばトランス アメリカン ソサェテ
ィ オブ アーティフィシャル オルガンズ(Trans A
merican Society of Artificial Organs(1987)、
第33巻、ページ6、スコラリー レビューズ(Schola
rly Reviews)“セル アドヘッション ツー バイオマ
テリアルズ(Cells Adhesion to Bimaterials)”)も
検討されている。
Regarding the former cell adhesion to the surface of the base material, it is known that the polystyrene-based material usually used as a plastic dish for tissue culture and the surface having an appropriate charge density are excellent. JP-A-2-169
No. 72 discloses a porous film having a cross-linked styrene-divinylbenzene polymer retained on the surface thereof, and a surface having an appropriate charge density is described in Journal of
Theological Biology (Journal of Theological
Biology), Vol. 49, pages 417-424 (19).
75): Adhesion and Spreading of Cells on Charged Surfaces
and Spreading of Cells on Charged Sarfaces). In addition, various polymer materials whose surfaces are subjected to surface treatments such as low temperature plasma treatment, sputtering treatment, ultraviolet treatment, electron beam treatment, and coating treatment of a monomolecular accumulated film (Japanese Patent Publication No. 58-32589, JP-A No. 63-19896).
7, JP-A-63-198977, JP-A-1-15133.
Etc.), or materials treated with cell adhesion factors or cell growth factors such as collagen, fibronectin, hydronectin, and laminin (for example, Trans American Society of Artificial Organs (Trans A
American Society of Artificial Organs (1987),
Volume 33, Page 6, Scholarly Reviews (Schola
rly Reviews) “Cells Adhesion to Bimaterials”) is also being considered.

【0005】しかし、高分子材料にポリスチレンを用い
て、上記表面処理を施した場合、ポリスチレンには良好
な細胞接着性が付与されるが、物性が脆弱なため、厚さ
の薄いフィルム状物や高密度培養に適した多孔質膜に成
形することは困難であるという欠点が生じる。また、細
胞培養基材が膜厚100μm程度の「多孔質膜」という
特殊な形状であると、一般的に行われている表面処理で
は「膜物性の劣化」や「孔径の閉塞化」等の問題が生じ
るものが多かった。
However, when polystyrene is used as the polymer material and subjected to the above-mentioned surface treatment, polystyrene has good cell adhesiveness, but its physical properties are weak, so that a thin film-like material or The drawback is that it is difficult to form a porous membrane suitable for high-density culture. In addition, when the cell culture substrate has a special shape of “porous membrane” with a thickness of about 100 μm, the surface treatment that is generally performed causes “deterioration of physical properties of membrane” and “blocking of pore diameter”. There were many problems.

【0006】また、基材表面をコラーゲンや細胞間マト
リックス(ECM),細胞接着因子などで処理すること
により肝細胞等の細胞の接着性や伸展性が向上するが、
これらの方法では使用前に無菌的にコーティング処理を
施さなければならず、そのため操作が煩雑となるという
欠点がある。また、雑菌混入の可能性が増える点からも
上記方法は好ましいとは言えない。さらに、高密度培養
による有用物質の生産を考えると、大量の膜を使用する
ため、コラーゲンや細胞接着因子の必要量が増大し、経
済的観点から問題点を有している。
Further, treatment of the surface of the base material with collagen, an intercellular matrix (ECM), a cell adhesion factor or the like improves the adhesion and spreadability of cells such as hepatocytes.
These methods have a drawback that the coating process must be performed aseptically before use, which makes the operation complicated. Further, the above method is not preferable also from the viewpoint of increasing the possibility of contamination by various bacteria. Furthermore, considering the production of useful substances by high-density culture, a large amount of membranes is used, so that the required amounts of collagen and cell adhesion factors increase, which poses a problem from an economical point of view.

【0007】一方、高密度培養細胞の成育環境維持につ
いては、多孔質膜を用いる方法が優れていると考えられ
ている。すなわち、多孔質平膜を積層したり、中空糸を
束ねることにより限られた容積内に多くの表面積を確保
でき、更に、生命活動に必要な物質の供給や異物の除去
を多孔質膜の微小な孔を介して連続的に拡散もしくは膜
間の圧力差により強制的に行うことによって良好な成育
環境を維持することが可能となる。特に、上皮細胞や内
皮細胞のように極性を有する細胞の場合、栄養源の吸収
や代謝が生理的条件と同様に接着基質側から行われるこ
とは、細胞にとって好ましいことである。
On the other hand, a method using a porous membrane is considered to be excellent for maintaining the growth environment of high density cultured cells. That is, by stacking porous flat membranes or bundling hollow fibers, it is possible to secure a large surface area within a limited volume. It is possible to maintain a good growth environment by continuously diffusing through the pores or by forcing by the pressure difference between the membranes. In particular, in the case of cells having polarity such as epithelial cells and endothelial cells, it is preferable for the cells that absorption and metabolism of nutrients be performed from the side of the adhesion substrate as in physiological conditions.

【0008】[0008]

【発明が解決しようとする課題】皮膚は唯一直接外界に
接している臓器であり、最下層に分裂能を有する基底細
胞層、その上層にある基底細胞が徐々に分化してできた
有刺層・顆粒層そして最外層の角質層から成り立ってい
る。基底細胞は分化するにつれ、細胞が扁平化し、細胞
質中にケラチンを蓄積し、最終的には完全にケラチンと
なり、外界に排泄される。このように皮膚のような上皮
系の基底細胞には、真皮側から栄養を補給し角質層に向
けて排泄するという細胞内分極が存在する。このような
特性から表皮基底細胞は、プラスチックシャーレ上で培
養すると基材との接着面より栄養補給ができず、培養を
続けていくと徐々に基材から剥離し死んでしまう。従っ
て、この細胞内分極という表皮細胞の特性を生かすため
には、細胞が接着している部分から栄養を摂取できなけ
ればならない。このため、物質透過性を持つ細胞培養用
基材が望まれる。コラーゲンからなる膜では、物質透過
性のないコラーゲン基材(プラスチックシャーレにコラ
ーゲンをコートしたもの)に比べ、表皮基底細胞が長期
保持が可能であったという報告がある(ジャーナル セ
ル セイエンス,Journal Cell Science, 第91号、ペ
ージ491〜499(1988))。しかし、コラーゲ
ン膜は栄養を補給できるだけの物質透過性もなく、また
物理的に不安定であり、更に表皮基底細胞が生産するコ
ラゲナーゼにより分解する可能性がある。
The skin is the only organ that is in direct contact with the outside world, and has a basal cell layer having a dividing ability in the lowermost layer and a barbed layer formed by gradually differentiating the basal cells in the upper layer.・ It is composed of a granular layer and the outermost stratum corneum. As the basal cells differentiate, the cells flatten, accumulate keratin in the cytoplasm, and finally become keratin completely, and are excreted to the outside world. Thus, in basal cells of epithelial system such as skin, there is an intracellular polarization in which nutrients are supplied from the dermis side and excreted toward the stratum corneum. Due to such characteristics, the epidermal basal cells cannot be supplemented with nutrients from the adhesive surface with the substrate when cultured on a plastic petri dish, and gradually peel off from the substrate and die when the culture is continued. Therefore, in order to take advantage of the characteristic of the epidermal cell, which is the intracellular polarization, it is necessary to be able to take in nutrients from the part where the cells are attached. Therefore, a substance-permeable substrate for cell culture is desired. It has been reported that a membrane made of collagen was capable of retaining epidermal basal cells for a long period of time, compared to a collagen substrate (a plastic petri dish coated with collagen) that does not have substance permeability (Journal Cell Science, Journal Cell Science). , No. 91, pages 491-499 (1988)). However, the collagen membrane is not permeable to nutrients to supplement nutrients, is physically unstable, and may be degraded by collagenase produced by epidermal basal cells.

【0009】また、近年培養移植法あるいは培養皮膚と
も言える皮膚に近い材料の移植法が行われてきている。
これは重度の患者を対象として、患者の残された正常部
位の皮膚を採取して、単離した細胞を試験管内で培養を
行い、もとの細胞の数十倍から数百倍に増殖したのち、
被覆膜とともに患者の創傷部位に移植してやり、表皮化
を形成させ治癒を図るものである。この方法を臨床に応
用した例として、ガリコら[G.G.Gallico et al.,]の
研究(ニューイングランド ジャーナル オブメディス
ン,第311巻、第7号、448〜451頁)[New En
gland Journal Medicine ,vol 311,No7、p448〜451(19
84)]がある。
[0009] In recent years, there has been performed a culture transplantation method or a transplantation method of a material similar to skin which can be called cultured skin.
This is for severe patients, and the skin of the remaining normal site of the patient is collected, and the isolated cells are cultured in a test tube to grow to several tens to several hundred times of the original cells. Later,
It is intended to be cured by being transplanted to a wound site of a patient together with a coating film to form epidermis. As an example of clinical application of this method, a study by [GGGallico et al.,] (New England Journal of Medicine, 311, No. 7, 448-451) [New En
gland Journal Medicine, vol 311, No7, p448〜451 (19
84)].

【0010】それに対して、人工材料による細胞培養用
基材は上記のコラーゲン膜の欠点を補うものとして市販
されているが、表皮基底細胞の接着性が低く、人工材料
において物質透過性膜の利点を補うものでは未だにな
い。
On the other hand, a cell culture substrate using an artificial material is commercially available as a material that compensates for the above-mentioned drawbacks of the collagen membrane. However, the adhesiveness of epidermal basal cells is low, and the advantage of the substance-permeable membrane in the artificial material. There is not yet a supplement.

【0011】[0011]

【課題を解決するための手段】本発明は上記事情を鑑
み、移植者の表皮細胞を生体外の基材上で培養して、そ
のまま皮膚欠損部に移植することができる人工皮膚基材
を提示することを目的とする。
In view of the above circumstances, the present invention presents an artificial skin substrate capable of culturing the epidermal cells of a transplanter on a substrate in vitro and directly transplanting it to a skin defect site. The purpose is to do.

【0012】上記目的は以下の構成による本発明により
達成される。
The above object is achieved by the present invention having the following constitution.

【0013】(1) 多孔質膜基材上に、増殖性がない
動物由来の線維芽細胞を存在させ、更に未分化の表皮基
底細胞が単層化されて存在しており、細胞を多孔質膜か
ら剥すことなく、細胞側を皮膚欠損部の創面に移植する
ことが可能な人工皮膚。
(1) A non-proliferative animal-derived fibroblast is present on a porous membrane substrate, and undifferentiated epidermal basal cells are present in a monolayered state, and the cells are porous. An artificial skin that can be transplanted from the cell side to the wound surface of the skin defect without peeling from the membrane.

【0014】(2) 線維芽細胞がマウス肺線維芽細胞
(3T3)、ヒト皮膚線維芽細胞とラット皮膚線維細胞
の少なくとも1つから選ばれる(1)に記載の人工皮
膚。
(2) The artificial skin according to (1), wherein the fibroblasts are selected from at least one of mouse lung fibroblasts (3T3), human skin fibroblasts and rat skin fibroblasts.

【0015】(3) 多孔質膜がアルコキシアルキルア
クリレートより選ばれる1種以上の重合体をグラフト重
合されたポリオレフィン及び一部もしくは全ての水素が
ハロゲン化されたポリオレフィンよりなる群から選ばれ
た少なくとも1種のものを主成分とする(1)または
(2)に記載の人工皮膚。
(3) At least one selected from the group consisting of a polyolefin in which the porous film is graft-polymerized with one or more polymers selected from alkoxyalkyl acrylates and a polyolefin in which some or all of the hydrogen is halogenated. The artificial skin according to (1) or (2), which is mainly composed of species.

【0016】(4) 多孔質膜の平均孔径が0.01〜
1.0μmである(1)から(3)のいずれかに記載の
人工皮膚。
(4) The average pore diameter of the porous membrane is 0.01 to
The artificial skin according to any one of (1) to (3), which has a thickness of 1.0 μm.

【0017】(5) 多孔質膜基材上に、γ線を0.0
3 Mrad 照射して増殖性のない状態にした3T3細胞を
1×104 〜1×105 cells/cm2 播種し培養した後、
更に表皮細胞を1×104 〜1×105 cells/cm2 (1
%牛胎児血清を含むカルシウム・フリーなDME培地に
懸濁)の範囲で播種し、37℃でインキューベトするこ
とにより、未分化の表皮細胞を単層化させ、細胞を多孔
質膜から剥すことなく、細胞側を皮膚欠損部の創面に移
植することが可能な人工皮膚の製造方法。
(5) 0.0 gamma rays were applied to the porous membrane substrate.
3T3 cells that had been irradiated with 3 Mrad to make them non-proliferative were seeded and cultured at 1 × 10 4 to 1 × 10 5 cells / cm 2 ,
Further, the epidermal cells were added to 1 × 10 4 to 1 × 10 5 cells / cm 2 (1
% Suspension in calcium-free DME medium containing fetal bovine serum) and incubating at 37 ° C to undifferentiate epidermal cells into a monolayer without removing the cells from the porous membrane. A method for producing artificial skin capable of transplanting the cell side to the wound surface of a skin defect.

【0018】又、本発明は下記の構成によっても達成さ
れる。
The present invention can also be achieved by the following constitution.

【0019】(6) 多孔質膜基材上に未分化の表皮基
底細胞が単層化されて存在しており、細胞を多孔質膜か
ら剥すことなく、細胞側を皮膚欠損部の創面に移植する
ことが可能な人工皮膚。
(6) Undifferentiated epidermal basal cells are present as a monolayer on the porous membrane substrate, and the cell side is transplanted to the wound surface of the skin defect without peeling the cells from the porous membrane. Artificial skin that can be.

【0020】(7) 多孔質膜がアルコキシアルキルア
クリレートより選ばれる1種以上の重合性単量体をグラ
フト重合されたポリオレフィン及び一部もしくは全ての
水素がハロゲン化されたポリオレフィンよりなる群から
選ばれた少なくとも1種のものを主成分とする(6)に
記載の人工皮膚。
(7) The porous film is selected from the group consisting of polyolefins graft-polymerized with one or more polymerizable monomers selected from alkoxyalkyl acrylates and polyolefins in which some or all of the hydrogen is halogenated. The artificial skin as described in (6), which contains at least one kind as a main component.

【0021】(8) 多孔質膜の平均孔径が0.01〜
1.0μmである(6)または(7)に記載の人工皮膚。
(8) The average pore diameter of the porous membrane is 0.01 to
The artificial skin according to (6) or (7), which has a thickness of 1.0 μm.

【0022】(9) 多孔質膜がプラズマ放電処理され
ていることを特徴とする(6)から(8)のいずれかに
記載の人工皮膚。
(9) The artificial skin as described in any one of (6) to (8), wherein the porous film is subjected to plasma discharge treatment.

【0023】(10) 多孔質膜基材上に、表皮基底細
胞を1×104 〜1×106 cells/cm2 (1%牛胎児血
清を含むカルシウム・フリーなDME培地に懸濁)の濃
度で播取し、更に37℃でインキュベートすることによ
り、未分化の表皮細胞を単層化させ、細胞を多孔質膜か
ら剥すことなく、細胞側を皮膚欠損部の創面に移植する
ことが可能な人工皮膚の製造方法。
(10) 1 × 10 4 to 1 × 10 6 cells / cm 2 (suspended in calcium-free DME medium containing 1% fetal bovine serum) of epidermal basal cells on a porous membrane substrate. By seeding at a concentration and further incubating at 37 ° C, undifferentiated epidermal cells can be monolayered, and the cell side can be transplanted to the wound surface of the skin defect without peeling the cells from the porous membrane. Method for producing simple artificial skin.

【0024】本発明において、物質透過性のある膜は平
均孔径0.01〜1.0μmの貫通孔を有する多孔質膜で
あるのが好ましい。このような膜としては、特に限定す
るものではないが、好ましくはポリプロピレンなどのポ
リオレフィンやポリフッ化ビニリデンなどのハロゲン化
ポリオレフィンが望ましく、更に上記の多孔質膜は疎水
性であるため、親水化されているのが望ましい。これ以
外の膜としては、ナイロン、ポリサルフォン、ポリビニ
ルテレフタレート、ニトロセルロース、再生セルロー
ス、酢酸セルロースなどがある。
In the present invention, the substance-permeable membrane is preferably a porous membrane having through holes having an average pore size of 0.01 to 1.0 μm. Such a film is not particularly limited, but is preferably a polyolefin such as polypropylene or a halogenated polyolefin such as polyvinylidene fluoride, and the above-mentioned porous film is hydrophobic, so that it is hydrophilized. Is desirable. Other membranes include nylon, polysulfone, polyvinyl terephthalate, nitrocellulose, regenerated cellulose, cellulose acetate and the like.

【0025】本発明に係わる人工皮膚は、多孔質膜基材
上に、γ線あるいはマイトマイシンCで処理された増殖
性がない動物由来の線維芽細胞が存在し、更に未分化の
表皮基底細胞が単層化されており、細胞を多孔質膜から
剥すことなく、細胞側を皮膚欠損部の創面に移植するこ
とを可能にするものである。この際に用いる多孔質膜
は、細胞増殖性、親水性、柔軟性の優れたポリアルコキ
シアルキルアクリレートが表面グラフト重合され、良好
な細胞接着性、耐脆弱性、親水性を施すことが望まし
い。また、ポリアルコキシアルキルアクリレートは、カ
チオン性やアニオン性の極性基を分子内に持たない適度
な親水性を有しているため、材料表面に吸着されるタン
パク質も静電的相互作用や疎水性相互作用がマイルドと
なり、そのため細胞に対して良好な成育環境が維持され
やすい。
In the artificial skin according to the present invention, non-proliferative animal-derived fibroblasts treated with γ-rays or mitomycin C are present on a porous membrane substrate, and undifferentiated epidermal basal cells are present. It is a monolayer, and enables the cell side to be transplanted to the wound surface of the skin defect portion without peeling the cell from the porous membrane. It is desirable that the porous membrane used in this case has good cell adhesion, fragility, and hydrophilicity by being surface-grafted with a polyalkoxyalkyl acrylate having excellent cell growth property, hydrophilicity, and flexibility. In addition, since polyalkoxyalkyl acrylate has moderate hydrophilicity without having a cationic or anionic polar group in the molecule, the protein adsorbed on the surface of the material also has electrostatic interaction or hydrophobic interaction. The action becomes mild, so that a good growth environment for cells is easily maintained.

【0026】また、アルコキシアルキルアクリレートを
構成成分とする重合体が、グラフト鎖として基材表面に
共有結合により導入されていると、コーティングや架橋
剤を用いた不溶化による被覆と異なり、重合体層が溶出
したり剥離することがなくなる。また、基材となる材料
が親水化処理された多孔質膜であると、事前に親水化処
理することなく使用することができ、更に培養液が膜の
孔に浸入し、通過できるようになり、膜上での高密度培
養が可能となる。
Further, when a polymer having an alkoxyalkyl acrylate as a constituent component is introduced as a graft chain onto the surface of the substrate by a covalent bond, the polymer layer is different from coating or insolubilization using a crosslinking agent. It does not elute or peel off. In addition, if the base material is a hydrophilized porous membrane, it can be used without prior hydrophilization, and the culture solution can penetrate and pass through the pores of the membrane. It enables high-density culture on the membrane.

【0027】また、γ線あるいはマイトマイシンCで処
理された増殖性がない動物由来の線維芽細胞が存在する
と、少量の表皮基底細胞を播種するだけでよい。この人
工皮膚を作製するには、まず移植すべき患者の皮膚の一
部をデルマトームで剥離し、表皮と真皮に分け、また予
め多孔質膜基材上にγ線処理より増殖性のない状態にし
た3T3細胞を104 〜1×105 cells/cm2 播種し、
1日培養した後更に表皮基底細胞を104 〜1×105
cells/cm2 の範囲で播種し、特に1%牛胎児血清を含む
カルシウム・フリーなDME培地を使用して、37℃で
3〜7日間位培養すると、自然に3T3細胞が多孔質膜
基材上から離脱し、直接単層化した未分化の表皮細胞が
多孔質膜基材上に接着することにより、細胞を多孔質膜
から剥すことなく、細胞側を皮膚欠損部の創面に移植す
ることが可能な人工皮膚が得られる。
In the presence of non-proliferative animal-derived fibroblasts treated with γ-rays or mitomycin C, a small amount of epidermal basal cells may be seeded. In order to produce this artificial skin, first, a part of the patient's skin to be transplanted is exfoliated with a dermatome to divide it into epidermis and dermis, and it is preliminarily made to have a nonproliferative state on a porous membrane substrate by γ-ray treatment. 3T3 cells were seeded at 10 4 to 1 × 10 5 cells / cm 2 ,
After culturing for 1 day, the epidermal basal cells were further added to 10 4 to 1 × 10 5.
Cells were seeded in the range of cells / cm 2 , and particularly when calcium-free DME medium containing 1% fetal bovine serum was used and cultured at 37 ° C for about 3 to 7 days, 3T3 cells spontaneously formed a porous membrane substrate. Undifferentiated epidermal cells, which have detached from the top and directly formed into a monolayer, adhere to the porous membrane substrate so that the cell side can be transplanted to the wound surface of the skin defect without peeling the cells from the porous membrane. It is possible to obtain artificial skin.

【0028】また、本発明に係わる人工皮膚は、多孔質
膜基材上に未分化の表皮基底細胞が単層化されており、
細胞を多孔質膜から剥すことなく、細胞側を皮膚欠損部
の創面に移植することを可能にするものである。この際
に用いる多孔質膜は、細胞増殖性、親水性、柔軟性を付
与するため、アルコキシアルキルアクリレートより選ば
れる1種以上の重合性単量体をグラフト重合されたポリ
オレフィン及び一部もしくは全ての水素がハロゲン化さ
れたポリオレフィンよりなる群から選ばれた少なくとも
1種のものを主成分とするものが好ましい。この人工皮
膚を作製するには、まず移植すべき患者の一部をデルマ
トームで剥離し、表皮と真皮に分け、更に表皮基底細胞
を1×104 〜1×106 cells/cm2 の範囲で多孔質膜
基材上に播種し、特に1%牛胎児血清を含むカルシウム
・フリーなDME培地を使用すると37℃でインキュベ
ートすることにより、未分化の表皮細胞が単層化するこ
とができ、細胞を多孔質膜から剥すことなく、細胞側を
皮膚欠損部の創面に移植することが可能な人工皮膚が得
られる。
In the artificial skin according to the present invention, undifferentiated epidermal basal cells are monolayered on the porous membrane substrate,
It is possible to transplant the cell side to the wound surface of the skin defect portion without peeling the cell from the porous membrane. The porous membrane used in this case is a polyolefin which is graft-polymerized with one or more polymerizable monomers selected from alkoxyalkyl acrylates and a part or all of them in order to impart cell growth property, hydrophilicity and flexibility. It is preferable that the main component is at least one selected from the group consisting of polyolefins in which hydrogen is halogenated. To prepare the artificial skin, a portion of the patient first to be transplanted were detached with dermatome, divided into epidermis and dermis, further epidermal basal cells in the range of 1 × 10 4 ~1 × 10 6 cells / cm 2 Undifferentiated epidermal cells can be monolayered by seeding on a porous membrane substrate and incubating at 37 ° C, especially when using calcium-free DME medium containing 1% fetal bovine serum, It is possible to obtain an artificial skin in which the cell side can be transplanted to the wound surface of the skin defect portion without peeling the cell from the porous membrane.

【0029】本発明において用いる線維芽細胞は特に限
定されないが、好ましくはマウス肺線維芽細胞(3T
3)、ヒト皮膚線維芽細胞とラット皮膚線維細胞が良
い。
The fibroblasts used in the present invention are not particularly limited, but preferably mouse lung fibroblasts (3T
3) Human dermal fibroblasts and rat dermal fibroblasts are good.

【0030】本発明において用いる表皮基底細胞は特に
限定されないが、好ましくはヒト皮膚、特に好ましくは
本発明の人工皮膚を移植される患者本人の皮膚がよい。
The epidermal basal cells used in the present invention are not particularly limited, but preferably human skin, particularly preferably the skin of the patient himself / herself who is transplanted with the artificial skin of the present invention.

【0031】以下、実施例を示し、本発明を具体的に説
明する。
Hereinafter, the present invention will be specifically described with reference to examples.

【0032】[0032]

【実施例】【Example】

(実施例1)メルトフローインデックスが30及び0.
3のポリプロピレン混合物(混合重量比100:40)
100重量部当り、400重量部の流動パラフィン(数
平均分子量324)及び0.3重量部の結晶核形成剤と
しての1,3,2,4−ビス(p−エチルベンジリデ
ン)ソルビトールを二軸型押出機により溶融し、ペレッ
ト化した。このペレットを上記押出機を用いて150〜
200℃で溶融し、スリット幅0.6mmのTダイより空
気中に押し出し、Tダイ直下に置かれた冷却液相のガイ
ドローラーの回転によって冷却固化液中に導き、冷却固
化して巻き取った。
(Example 1) Melt flow index was 30 and 0.
Polypropylene mixture of 3 (mixing weight ratio 100: 40)
400 parts by weight of liquid paraffin (number average molecular weight 324) and 0.3 parts by weight of 1,3,2,4-bis (p-ethylbenzylidene) sorbitol as a crystal nucleating agent per 100 parts by weight of biaxial type. It was melted by an extruder and pelletized. The pellets are heated to 150-
Melted at 200 ° C, extruded into the air from a T-die having a slit width of 0.6 mm, guided into a cooling and solidifying liquid by rotation of a guide roller for a cooling liquid phase placed immediately below the T-die, cooled and solidified and wound up. ..

【0033】巻き取ったフィルム状物を一定長に切断
し、縦横両方向を固定し、1,1,2−トリクロロ−
1,2,2−トリフルオロエタン中に10分間計4回浸
漬して流動パラフィンの抽出を行い、次いで135℃の
空気中で10分間計4回浸漬して流動パフィンの抽出を
行い、次いで135℃の空気中で2分間処理を行って、
孔径0.45μm、膜厚120μmのポリプロピレン製
多孔質膜を得た。
The wound film-like material is cut into a certain length, fixed in both longitudinal and lateral directions, and 1,1,2-trichloro-
Liquid paraffin was extracted by immersing it in 1,2,2-trifluoroethane for a total of 4 times for 10 minutes, and then for a total of 4 times for 10 minutes in air at 135 ° C. to extract a liquid puffin, and then 135 After treating in air at ℃ for 2 minutes,
A polypropylene porous film having a pore size of 0.45 μm and a film thickness of 120 μm was obtained.

【0034】このようにして得られた多孔質膜に低温プ
ラズマ(アルゴン、0.1ton)を15秒間照射した後、メ
トキシエチルアクリレートの単量体をガス状で供給し、
288Kの温度で5分間表面グラフト重合を行った。グ
ラフト重合後、未反応の単量体を減圧脱気して、0.0
1ton 以下にし、更にプラズマ放電処理を0.1ton、2
0秒間(100W)行った。このようにして得られた膜
をジクロロメタン/メタノール共沸溶媒で2日間洗浄し
た後乾燥させた。
The porous film thus obtained was irradiated with low-temperature plasma (argon, 0.1 ton) for 15 seconds, and then a methoxyethyl acrylate monomer was supplied in a gaseous state,
Surface graft polymerization was carried out at a temperature of 288K for 5 minutes. After the graft polymerization, the unreacted monomer was degassed under reduced pressure to 0.0
1ton or less, and plasma discharge treatment 0.1ton, 2
The operation was performed for 0 seconds (100 W). The membrane thus obtained was washed with a dichloromethane / methanol azeotropic solvent for 2 days and then dried.

【0035】一方、予め3T3細胞(種類NIH、大日
本製薬(株)より入手、ATCC No.CRL1658)を10%C
S(Calf Serum)−DME(Dulbecoo's Modified Eagle
Medium)懸濁液を3×105 cells/mlに調整し、18
0秒間γ線を照射した後、1000r.p.m.5分間遠心分
離し、最終的に8×104 cells/cm2 で上記で作製した
多孔質膜基材上に播種した。更に、1日培養後、培養液
を除去し、ヒト新生児皮膚から酵素処理により採取した
ヒト角化細胞を1%牛胎児血清を含むカルシウム・フリ
ーなDME培地に懸濁し、1×104 cells/cm2 で播種
し、二酸化炭素雰囲気下でインキュベーターにて7日間
培養人工皮膚を作製した。
On the other hand, 10% C of 3T3 cells (type NIH, obtained from Dainippon Pharmaceutical Co., Ltd., ATCC No. CRL1658) were previously prepared.
S (Calf Serum) -DME (Dulbecoo's Modified Eagle
Medium) suspension to 3 × 10 5 cells / ml,
After irradiating with γ-ray for 0 second, it was centrifuged at 1000 rpm for 5 minutes, and finally seeded at 8 × 10 4 cells / cm 2 on the porous membrane substrate prepared above. Furthermore, after culturing for 1 day, the culture solution was removed, and human keratinocytes collected by enzymatic treatment from human neonatal skin were suspended in calcium-free DME medium containing 1% fetal bovine serum, and 1 × 10 4 cells / The seeds were sown in cm 2 , and cultured artificial skin was produced for 7 days in an incubator under a carbon dioxide atmosphere.

【0036】当該人工皮膚を皮膚欠損創を作製したヌ
ードマウスに未分化の表皮細胞を創面側にして移植する
と、21日目には生着したことが組織学的に確認でき
た。
When the artificial skin was transplanted to a nude mouse having a skin defect wound with undifferentiated epidermal cells on the wound surface side, it was confirmed histologically that it was engrafted on the 21st day.

【0037】(実施例2)ポリフッ化ビニリンデン粉末
(三菱油化(株)製、Kynar K301)18重量部をア
セトン73.8重量部及びジメチルホルムアミド8.2重
量部に溶解してなる溶液を、ポリエチレンテレフタレー
トフィルム上にキャストした後、1,1,2−トリクロ
ロトリフルオロエタン浴中に5分間浸漬し、乾燥して膜
厚125μm、平均孔径0.45μmのポリフッ化ビニ
リデン製多孔質膜を得た。
Example 2 A solution prepared by dissolving 18 parts by weight of polyvinylidene fluoride powder (Kynar K301, manufactured by Mitsubishi Petrochemical Co., Ltd.) in 73.8 parts by weight of acetone and 8.2 parts by weight of dimethylformamide was prepared. After casting on a polyethylene terephthalate film, it was immersed in a 1,1,2-trichlorotrifluoroethane bath for 5 minutes and dried to obtain a polyvinylidene fluoride porous film having a thickness of 125 μm and an average pore diameter of 0.45 μm. ..

【0038】このようにして得られた多孔質膜に実施例
1と同様に表面グラフト重合及びプラズマ放電処理まで
の処理を行い、得られた試料について実施例1と同様に
してヒト表皮細胞を播種し7日間培養し、人工皮膚を
作製した。
The porous membrane thus obtained was subjected to surface graft polymerization and plasma discharge treatment in the same manner as in Example 1, and the obtained sample was seeded with human epidermal cells in the same manner as in Example 1. Then, it was cultured for 7 days to prepare artificial skin.

【0039】当該人工皮膚をヌードマウスに移植した
結果、表皮細胞を生着した。
As a result of transplanting the artificial skin into a nude mouse, epidermal cells were engrafted.

【0040】(実施例3)メルトフローインデックスが
30及び0.3のポリプロピレン混合物(混合重量比1
00:40)100重量部当り、400重量部の流動パ
ラフィン(数平均分子量324)及び0.3重量部の結
晶核形成剤としての1,3,2,4−ビス(p−エチル
ベンジリデン)ソルビトールを二軸型押出機により溶融
し、ペレット化した。このペレットを上記押出機を用い
て150〜200℃で溶融し、スリット幅0.6mmのT
ダイより空気中に押し出し、Tダイ直下に置かれた冷却
液相のガイドローラーの回転によって冷却固化液中に導
き、冷却固化した後巻き取った。
Example 3 A polypropylene mixture having a melt flow index of 30 and 0.3 (mixing weight ratio: 1)
00:40) 400 parts by weight of liquid paraffin (number average molecular weight 324) and 0.3 parts by weight of 1,3,2,4-bis (p-ethylbenzylidene) sorbitol as a crystal nucleating agent per 100 parts by weight. Was melted by a twin-screw extruder and pelletized. The pellets were melted at 150 to 200 ° C. using the above extruder, and the T having a slit width of 0.6 mm was used.
It was extruded into the air from the die, guided to the cooling and solidifying liquid by the rotation of the guide roller for the cooling liquid phase placed immediately below the T die, cooled and solidified, and then wound.

【0041】巻き取ったフィルム状物を一定長に切断
し、縦横両方向を固定し、1,1,2−トリクロロ−
1,2,2−トリフルオロエタン中に10分間計4回浸
漬して流動パラフィンの抽出を行い、次いで135℃の
空気中で10分間計4回浸漬して流動パラフィンの抽出
を行い、次いで135℃の空気中で2分間熱処理を行っ
て、孔径0.45μm、膜厚120μmのポリプロピレ
ン製多孔質膜を得た。このようにして得られた多孔質膜
に低温プラズマ(アルゴン、0.1Torr)を15秒間照射
した後、メトキシエチルアクリレートの単量体をガス状
で供給し、288Kの温度で5分間表面グラフト重合を
行った。グラフト重合後、未反応の単量体を減圧脱気し
て、0.01ton 以下にし、更にプラズマ放電処理を0.
1ton 、20秒間(100W)行った。このようにして
得られた膜をジクロロメタン/メタノール共沸溶媒で2
日間洗浄した後乾燥させた。
The wound film-like material is cut into a certain length, fixed in both longitudinal and lateral directions, and 1,1,2-trichloro-
The liquid paraffin was extracted by immersing it in 1,2,2-trifluoroethane for a total of 4 times for 10 minutes, and then in the air at 135 ° C for a total of 4 times for 10 minutes to extract the liquid paraffin, and then 135 A heat treatment was performed for 2 minutes in air at 0 ° C. to obtain a polypropylene porous film having a pore size of 0.45 μm and a film thickness of 120 μm. The porous film thus obtained was irradiated with low temperature plasma (argon, 0.1 Torr) for 15 seconds, and then a monomer of methoxyethyl acrylate was supplied in a gaseous state, and surface graft polymerization was performed at a temperature of 288K for 5 minutes. I went. After the graft polymerization, the unreacted monomer was degassed under reduced pressure to 0.01 ton or less, and further plasma discharge treatment was conducted to 0.02.
The operation was performed at 1 ton for 20 seconds (100 W). The membrane thus obtained was washed with dichloromethane / methanol azeotropic solvent
It was washed for a day and dried.

【0042】この多孔質膜基材上に、ヒト皮膚から酵素
処理により採取したヒト角化細胞を1%牛胎児血清を含
むカルシウム・フリーなダルベッコ改変イーグル培地
(DME)に懸濁し、1×105 cells/cm2 で播種し、
二酸化炭素雰囲気下でインキュベーターにて7日間培養
し、人工皮膚を作製した。
On this porous membrane substrate, human keratinocytes collected from human skin by enzyme treatment were suspended in calcium-free Dulbecco's modified Eagle medium (DME) containing 1% fetal bovine serum, and 1 × 10 6. Seed at 5 cells / cm 2 ,
It was cultured in an incubator for 7 days under a carbon dioxide atmosphere to prepare artificial skin.

【0043】当該人工皮膚を皮膚欠損創を作製したヌ
ードマウスに未分化の表皮細胞を創面側にして移植する
と、21日目には生着したことが組織学的に認識でき
た。
When the artificial skin was transplanted to a nude mouse having a skin defect wound with undifferentiated epidermal cells on the wound side, it was recognized histologically that it had engrafted on the 21st day.

【0044】(実施例4)ポリフッ化ビニリデン粉末
(三菱油化株式会社製、Kynar K301)18重量部を
アセトン73.8重量部及びジメチルホルムアミド8.2
重量部に溶解してなる溶液を、ポリエチレンテレフタレ
ートフィルム上にキャストした後、1,1,2−トリク
ロロトリフルオロエタン浴中に5分間浸漬し、乾燥して
膜厚125μm、平均孔径0.45μmのポリフッ化ビ
ニリデン製多孔質膜を得た。
Example 4 18 parts by weight of polyvinylidene fluoride powder (Kynar K301, manufactured by Mitsubishi Petrochemical Co., Ltd.) was added to 73.8 parts by weight of acetone and 8.2 parts of dimethylformamide.
After casting a solution prepared by dissolving 1 part by weight on a polyethylene terephthalate film, it is immersed in a 1,1,2-trichlorotrifluoroethane bath for 5 minutes and dried to give a film thickness of 125 μm and an average pore diameter of 0.45 μm. A porous film made of polyvinylidene fluoride was obtained.

【0045】このようにして得られた多孔質膜に実施例
1と同様に表面グラフト重合及びプラズマ放電処理まで
の処理を行い、得られた試料について実施例1と同様に
してヒト表皮細胞を播種し、7日間培養し、人工皮膚
を作製した。当該人工皮膚 4をヌードマウスに移植した
結果、表皮細胞は生着した。
The porous membrane thus obtained was subjected to surface graft polymerization and plasma discharge treatment in the same manner as in Example 1, and the obtained sample was seeded with human epidermal cells in the same manner as in Example 1. Then, it was cultured for 7 days to prepare artificial skin. As a result of transplanting the artificial skin 4 into a nude mouse, epidermal cells were engrafted.

【0046】(比較例1)ポリプロピレンフィルム(フ
ィルム膜厚:60μm、二村化学株式会社製、FOP#
60)をチャンバーに設置し、0.01ton 以下に減圧
した後、低温プラズマ(アルゴン0.1ton)を15秒間
照射し、再び0.01ton 以下に減圧し、更にメトキシ
エチルアクリレートなどのアルコキシアルキルアクリレ
ートの単量体をガス状で供給し、288Kの温度で5分
間表面グラフト重合を行った。グラフト重合後は、未反
応の単量体を減圧脱気して、0.01ton 以下にし、続
いてプラズマ放電処理を0.1ton、20秒間(100
W)行った。このようにして得られた膜をジクロロメタ
ン/メタノール共沸溶媒で2日間洗浄した後、乾燥し
た。得られた試料について実施例1及び3と同様にヒト
表皮細胞を播種し、基材上に表皮細胞は接着したが、ヌ
ードマウスに移植しても生着しにくかった。
Comparative Example 1 Polypropylene film (film thickness: 60 μm, manufactured by Nimura Chemical Co., Ltd., FOP #
60) is placed in the chamber and the pressure is reduced to 0.01 tons or less, then low temperature plasma (0.1 ton of argon) is irradiated for 15 seconds, the pressure is reduced again to 0.01 tons or less, and further alkoxyalkyl acrylate such as methoxyethyl acrylate is added. The monomer was supplied in a gaseous state, and surface graft polymerization was performed at a temperature of 288K for 5 minutes. After the graft polymerization, the unreacted monomer was degassed under reduced pressure to 0.01 ton or less, and then plasma discharge treatment was performed for 0.1 ton for 20 seconds (100 tons).
W) I went. The membrane thus obtained was washed with a dichloromethane / methanol azeotropic solvent for 2 days and then dried. Human epidermal cells were seeded on the obtained samples in the same manner as in Examples 1 and 3, and the epidermal cells adhered to the substrate, but they were hard to engraft even when transplanted to nude mice.

【0047】[0047]

【発明の効果】本発明の人工皮膚は多孔質膜基材上に、
γ線あるいはマイトマイシンCで処理された増殖性がな
い動物由来の線維芽細胞が存在し、更に未分化の表皮基
底細胞が単層化されており、細胞を多孔質膜から剥すこ
となく、細胞側を皮膚欠損部の創面に移植することを可
能にできる。また、本発明の人工皮膚は親水化処理され
た多孔質膜基材上に、未分化の表皮基底細胞が単層化さ
れており、細胞を多孔質膜から剥すことなく、細胞側を
皮膚欠損部の創面に移植することを可能にしたものであ
る。
The artificial skin of the present invention comprises a porous membrane substrate,
There are non-proliferative animal-derived fibroblasts treated with γ-rays or mitomycin C, and undifferentiated epidermal basal cells are monolayered. Can be transplanted to the wound surface of the skin defect. In addition, the artificial skin of the present invention has a monolayer of undifferentiated epidermal basal cells on a hydrophilized porous membrane substrate, and the cell side does not have to be peeled off from the porous membrane to cause a skin defect. It was made possible to be transplanted to the wound surface of the part.

【0048】これら本発明の人工皮膚を皮膚欠損部へ移
植すると、治癒過程を著しく短縮することができる。
When these artificial skins of the present invention are transplanted into a skin defect, the healing process can be shortened remarkably.

Claims (2)

【特許請求の範囲】[Claims] 【請求項1】 多孔質膜基材上に増殖性がない動物由来
の線維芽細胞を存在させ、更に未分化の表皮基底細胞が
単層化されて存在していることを特徴とする人工皮膚。
1. An artificial skin characterized in that non-proliferative animal-derived fibroblasts are present on a porous membrane substrate, and undifferentiated epidermal basal cells are present as a monolayer. ..
【請求項2】 表面を親水化処理した多孔質膜基材上に
未分化の表皮基底細胞が単層化されて存在していること
を特徴とする人工皮膚。
2. An artificial skin in which undifferentiated epidermal basal cells are present as a monolayer on a porous membrane base material whose surface has been hydrophilized.
JP4127532A 1992-05-20 1992-05-20 Artificial skin Pending JPH05317406A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP4127532A JPH05317406A (en) 1992-05-20 1992-05-20 Artificial skin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP4127532A JPH05317406A (en) 1992-05-20 1992-05-20 Artificial skin

Publications (1)

Publication Number Publication Date
JPH05317406A true JPH05317406A (en) 1993-12-03

Family

ID=14962349

Family Applications (1)

Application Number Title Priority Date Filing Date
JP4127532A Pending JPH05317406A (en) 1992-05-20 1992-05-20 Artificial skin

Country Status (1)

Country Link
JP (1) JPH05317406A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007006987A (en) * 2005-06-28 2007-01-18 Hokkaido Univ Structure for preparing cell sheet for skin regeneration and its utilization
JP2008200520A (en) * 2002-03-06 2008-09-04 Univ Of Cincinnati Surgical device for skin therapy or testing

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008200520A (en) * 2002-03-06 2008-09-04 Univ Of Cincinnati Surgical device for skin therapy or testing
US7741116B2 (en) 2002-03-06 2010-06-22 University Of Cincinnati Surgical device for skin therapy or testing
JP2011172592A (en) * 2002-03-06 2011-09-08 Univ Of Cincinnati Surgical device for skin therapy or testing
US8765468B2 (en) 2002-03-06 2014-07-01 University Of Cincinnati Surgical device for skin therapy or testing
US9089417B2 (en) 2002-03-06 2015-07-28 Steven T. Boyce Surgical device for skin therapy or testing
JP2007006987A (en) * 2005-06-28 2007-01-18 Hokkaido Univ Structure for preparing cell sheet for skin regeneration and its utilization

Similar Documents

Publication Publication Date Title
JP6069384B2 (en) Temperature-responsive cell culture equipment and method for producing the same
US8889417B2 (en) Epidermal cultured cell sheet, multi-layered cultured skin sheet and processes for producing those sheets
CA2012309A1 (en) Cell culture substrate, cell sheet, cell cluster and preparations thereof
JP2003038170A (en) Anterior eye part-associated cell sheet, three- dimensional structure and method for producing them
JP2006320304A (en) Closed cell culture container and method for culturing cell with the container
JPS6133593B2 (en)
JP2017074050A (en) Method for maintaining function of liver tissue cell over long period of time
JP2008271912A (en) Closed cell culture vessel and method for culturing cell therewith
US7695958B2 (en) Cell-filled hollow fiber membranes having modified cross-section
JP4874514B2 (en) Method for stratifying culture of epithelial cells, stratified epithelial cell sheet obtained therefrom, and method of use thereof
JPS63196281A (en) Substrate for cell culture
JP5252828B2 (en) Epithelial cell culture method
JP5227223B2 (en) Cell culture support
JPH03266980A (en) Base material for cell culture and production of cell aggregate using same
JPH05317406A (en) Artificial skin
JPS63196273A (en) Substrate for cell culture
JPH04237492A (en) Formed product for culturing cell
Takezawa et al. Mass transport via naturally branched scaffolds maintains viability of a reconstituted model of connective tissue
JP2013138690A (en) Closed cell culture vessel and cell culture method using the same
JP2010088416A (en) Tool for moving cultured cell and its utilization
JP2834456B2 (en) Cell culture method
CN115418344A (en) Method for simply and rapidly preparing patterned cell film
JPS63196279A (en) Substrate for cell culture
JPS63196277A (en) Substrate for cell culture
JPS63196278A (en) Substrate for cell culture